[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ictal Group\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":58},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100320899","status-epilepticus-in-the-critically-ill-patients-100320899",false,"NCT03457831","Status Epilepticus in the Critically Ill Patients","Inclusion Criteria:\n\n* SE defined as 5 min or more of (i) continuous clinical and\u002For electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures.\n* age \\>= 18 years\n\nExclusion Criteria:\n\n* age \\\u003C 18 years\n* postanoxic status epilepticus",true,"ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","10 Years","OBSERVATIONAL","Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus prospective registry.\n\nData collection using a standardized form : demographic data and data related to the SE, including circumstances of onset, dates and times of onset and of seizure control, on-scene clinical findings, clinical features of the seizures, pre-hospital and hospital care providers, timing of antiepileptic and supportive treatments, results of etiological investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and\u002For neurologist charts and\u002For patients phone interview.",[25],"Status Epilepticus","RECRUITING","2020-10-20",{"date":29,"type":30},"2020-10-22","ACTUAL",{"date":32,"type":30},"2018-02-28",{"date":34,"type":20},"2028-12-31",{"name":36,"class":37},"Ictal Group","OTHER",20,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":45,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":47,"conditions":48,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":56,"locationsCount":57},"100321867","posterior-reversible-encephalopathy-syndrome-in-the-critically-ill-patients-100321867","NCT03470467","Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients","Inclusion Criteria:\n\n* age \\>= 18 years\n* Posterior Reversible Encephalopathy Syndrome defined as:\n\n  * combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea\u002Fvomiting, and focal neurological signs AND\n  * cerebral imaging abnormalities involving the white matter (brain CT scan hypodensities AND\u002FOR Brain MRI hypoT1, hyper T2 FLAIR)\n* intensive care unit admission\n\nExclusion Criteria:\n\n* normal cerebral imaging",{"count":46,"type":20},300,"Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and\u002For neurologist charts and\u002For patients phone interview",[49],"Posterior Reversible Encephalopathy Syndrome","2019-08-07",{"date":52,"type":30},"2019-08-08",{"date":54,"type":30},"2018-03-09",{"date":34,"type":20},{"name":36,"class":37},1,""]